Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22172433 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: testosterone gel;   Drug: placebo gel

Study has passed its completion date and status has not been verified in more than two years.